Official Title
Study of Neurological Damage From Coronavirus Disease (COVID-19): Extraction of Quantitative Imaging Biomarkers for the Characterization of Pathological Profiles
Brief Summary

The objective of this study is to support the exploration of the NEURO-COVID-19 databaseand in particular to carry out the post-treatments necessary to derive quantitativeinformation on the characterization of the lesion load, in particular with regard to ofthe vascular tree

Detailed Description

Not Provided

Unknown status
COVID-19
Eligibility Criteria

Inclusion criteria:

- Adult patient (≥18 years old)

- COVID + patient presenting with neurological symptoms leading to an MRI.

- Patient taken care of in one of the care centers associated with this research

- Patient not having expressed his opposition, after information, to the reuse of his
data for the purposes of this research.

Exclusion criteria:

- Patient who expressed his opposition to participating in the study

- COVID patient not having neurological symptoms or not having received an MRI

- Patient under guardianship or guardianship

- Patient under legal protection

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
France
Locations

Service d'Imagerie 2 - Neuroradiologie et Radiologie Ostéo-articulaire - Hôpitaux Universitaires de Strasbourg
Strasbourg, France

Investigator: Stephane Kremer, MD, PhD
Contact: 33 3 88 12 78 89
stephane.kremer@chru-strasbourg.fr

Contacts

Stephane Kremer, MD, PhD
33 3 88 12 78 89
stephane.kremer@chru-strasbourg.fr

Saïd CHAYER, PhD, HDR
said.chayer@chru-strasbourg.fr

Not Provided

University Hospital, Strasbourg, France
NCT Number
Keywords
Covid-19
SARS-CoV-2
Central Nervous System
Headache
Loss of Smell
Coma
MeSH Terms
COVID-19
Trauma, Nervous System